MEDIZEN HUMANCARE Inc. (XKON:236340)
South Korea · Delayed Price · Currency is KRW 1,900.00
-200.00 (-9.52%)
At close: Oct 2, 2026
MEDIZEN HUMANCARE Market Cap
MEDIZEN HUMANCARE has a market cap or net worth of 4.38 billion as of October 2, 2026. Its market cap has increased by 5.56% in one year.
Market Cap
4.38B
Enterprise Value
n/a
Revenue
583.88M
Ranking
n/a
PE Ratio
n/a
Stock Price
1,900.00
ChartMarket Cap Chart
Since April 5, 2017, MEDIZEN HUMANCARE's market cap has decreased from 20.81B to 4.38B, a decrease of -78.96%. That is a compound annual growth rate of -15.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 4.38B | 11.76% |
| Dec 30, 2025 | 3.92B | -46.03% |
| Dec 30, 2024 | 7.26B | -21.25% |
| Dec 28, 2023 | 9.22B | -33.88% |
| Dec 29, 2022 | 13.94B | -13.57% |
| Dec 30, 2021 | 16.13B | -15.87% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Penetrium Bioscience | 412.92B |
| DreamCIS | 89.05B |
| HLB bioStep | 52.56B |
| P&K Skin Research Center | 48.29B |
| Kolmar BioTech | 38.46B |
| SLS BIO | 26.89B |
| C&R Research | 26.38B |
| DT&CRO CO. | 26.34B |